AOD-9604 is generally well-tolerated with a favorable safety profile based on clinical research involving approximately 900 participants across six studies

Sources: Neelakantan et al., Biochem Pharmacol 2018 | Dimet-Wiley et al., Sci Rep 2024 Security Profile & Chemical Identity Molecular specifications and preclinical safety data 5-Amino-1MQ Chemical Identity A small molecule derived from quinolinium salts, developed at the University of Texas (2017) 5-Amino-1MQ Tolerance & Status Safety data from preclinical studies (DIO mouse model) Published Preclinical Data 3 key studies published in Biochemical Pharmacology and Scientific Reports 35% Reduction of white adipose tissue in 11 days (20 mg/kg, 3 times/day) Physical Effects (11 days) + 40 % Improvement of grip strength in aged mice (22-24 months) Strength & Performance (aged mice) microbiome The combination of 5-Amino-1MQ + caloric restriction establishes a distinct gut microbial profile Protocol & Results Important Notice Search Only Not intended for human consumption

BPC-157 BPC-157/TB500 Recovery Blend No-Copper Recovery Blend (BPC-157/ TB500/KPV/ GHK-Cu) Sexual Function Peptides that enhance sexual function by improving blood flow, boosting libido, and supporting hormonal balance
There is no downtime with this groundbreaking procedure and most patients go back to their routines right afterwards, making it one of the most popular non-invasive methods to lose stubborn fat
[5] [6] [7] Mechanism of action [edit] AOD9604 appears to enhance lipolysis in mice by upregulating beta-3 adrenergic receptors